Upgrade to SI Premium - Free Trial

Dyne Therapeutics (DYN) PT Lowered to $37 at Raymond James

September 8, 2026 10:39 AM
Raymond James analyst Michael Freeman lowered the price target on Dyne Therapeutics (NASDAQ: DYN) to $37.00 (from $40.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change